News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
July, 2025
July 2025
M T W T F S S
 123456
78910111213
14151617181920
21222324252627
28293031  
Rami Manochakian: FLAURA2 Trial Update on EGFR+ Advanced Lung Cancer
Rami Manochakian/X
Jul 21, 2025, 15:04

Rami Manochakian: FLAURA2 Trial Update on EGFR+ Advanced Lung Cancer

Rami Manochakian, Vice President of the North American Neuroendocrine Tumor Society, shared a post on X:

“Hot Off the Press. Big News Press Release by AstraZeneca.

FLAURA2 trial of Osimertinib + Chemotherapy vs Osimertinib in 1st line Therapy for patients with EGFR+ advanced Lung Cancer (NSCLC) shows: Statistically Significant and Clinically Meaningful Improvement in Overall Survival.”

FLAURA2 Trial

More posts featuring Rami Manochakian.

AstraZeneca cancer FLAURA2 Trial OncoDaily Oncology Rami Manochakian
Special Coverage
Blog
Jul 21, 2025, 15:06
Anju Aledia: Fighting Cancer is Tough, But Feelings Matter
Blog
Jul 21, 2025, 15:04
Rami Manochakian: FLAURA2 Trial Update on EGFR+ Advanced Lung Cancer
Insight
Jul 21, 2025, 14:57
E. Shyam P. Reddy: Promising Leap Toward Treating Alpha-1 Antitrypsin Deficiency
Blog
Jul 21, 2025, 14:48
Kefah Mokbel: Can We Predict Who Needs Radiation Therapy after Lumpectomy for DCIS?
Blog
Jul 21, 2025, 14:47
Trijn Israels: The 'Missing Link' to Improving Childhood Cancer Outcomes in LMICs
Insight
Jul 21, 2025, 14:43
Hung Trinh: iNKT Cells at the Interplay Between Innate and Adaptive Immune Responses
Insight
Jul 21, 2025, 14:36
Hung Trinh: Generation of CAR T Cells Using Lentiviral Vector
Blog
Jul 21, 2025, 14:35
Douglas Flora: The Coming Wave - Why AI Might Be Unstoppable
Blog
Jul 21, 2025, 14:32
Hasti Donyagardrad: Excited to be Volunteering at the ESO-OncoDaily Educational Workshop
Blog
Jul 21, 2025, 14:30
Binay Shah: Inspired After an Outstanding Best of ASCO Hosted by Binaytara
Blog
Jul 21, 2025, 14:29
Jennifer Douglas: Breast Cancer Decisions Aren’t Just Medical, They’re Personal
Insight
Jul 21, 2025, 14:22
Zhe Wang: DT2216's Potential as a Targeted Therapy for MPN AML